The challenge of traditional Chinese medicines for allopathic practitioners

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 297, Issue 6, 2009, Pages

  Karalliedde, L D ^a   Kappagoda, C T ^b  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHINESE DRUG; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GRAPE SEED EXTRACT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERSTITIAL COLLAGENASE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRATE; OXIDIZED LOW DENSITY LIPOPROTEIN; POLYPHENOL DERIVATIVE; PROTEIN P53; SIMVASTATIN; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TONGXINLUO; UNCLASSIFIED DRUG;

ALGORITHM; ALLOPATHY; ANGINA PECTORIS; ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; AORTA ATHEROSCLEROSIS; APOPTOSIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHINA; CHINESE MEDICINE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COCHRANE LIBRARY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; EDITORIAL; ENDOTHELIUM CELL; FOOD AND DRUG ADMINISTRATION; GENERAL PRACTITIONER; HERBAL MEDICINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; PRIORITY JOURNAL; STANDARDIZATION; UNSTABLE ANGINA PECTORIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; AORTIC DISEASES; AORTIC RUPTURE; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CARDIOVASCULAR AGENTS; COMPLEMENTARY THERAPIES; DISEASE PROGRESSION; DRUGS, CHINESE HERBAL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION MEDIATORS; LIPIDS; SIMVASTATIN;

EID: 72249112530     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00944.2009     Document Type: Editorial

References (14)

1. Chen WQ, Zhang LZ, Ji XP, Zhao YX, Zhang C, HJ, Wu YL, Zhang Y. Chinese medicine tongxinluo significantly lowers serum lipid levels and stabilizes vulnerable plaques in a rabbit model. J Ethnopharmacol 124: 103-110, 2009.
2. Edirisinghe I, Burton-Freeman B, Kappagoda T. Mechanism of the endothelium-dependent relaxation evoked by a grape seed extract. Clinical Science 114: 331-337, 2008. (Pubitemid 351294009)
3. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 328: 246-252, 1993. (Pubitemid 23035311)
4. Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2497, 2001.
5. Food and Drug Administration. http://www.fda.gov/ohrms/dockets/ dockets/95s0316/rpt0099-01.pdf Accessed October 16, 2009.
6. Foucart S, Wang R, Moreau P, Sauvé R, de Champlain J, Yamaguchi N, Bai L, Lu XR. Effects of Buthus martensii Karsch scorpion venom on the release of noradrenalin. Can J Physiol Pharmacol 72: 855-861, 1994.
7. Jha V, Chugh KS. Nephropathy associated with animal, plant, and chemical toxins in the tropics. Semin Nephrol 23: 49-65, 2003. (Pubitemid 36164469)
8. Karalliedde L, Gawarammana I. Traditional Herbal Medicines - A Guide to Their Safer Use. London: Hammersmith, 2009.
9. Nose M, Tamura M, Ryu N, Mizukami H, Ogihara Y. Sho-saiko-to and Saiko-keisi-to, the traditional Chinese and Japanese herbal medicines, altered hepatic drug-metabolizing enzymes in mice and rats when administered orally for a long time. J Pharm Pharmacol 55: 1419-1426, 2003. (Pubitemid 37321386)
10. Rulis AM. Agency Response Letter GRAS Notice No. GRN 000013: CFSAN/Office of Premarket Approval. http://www.fda.gov/Food/Food IngredientsPackaging/ GenerallyRecognizedasSafeGRAS/GRASListings/ ucm154898. htm accessed October 16, 2009.
11. Woolf AD, Hussain J, McCullough L, Petranovic M, Chomchai C. Infantile lead poisoning from an Asian tongue powder: a case report & subsequent public health inquiry. Clin Toxicol (Phila) 46: 841-844, 2008.
12. Wu T, Harrison RA, Chen X, Ni J, Zhou L, Qiao J, Wang Q, Wei J, Xin D, Zheng J. Tongxinluo (Tong xin luo or Tong-xin-luo) capsule for unstable angina pectoris. Cochrane Database Syst Rev 4: CD004474, 2006. (Pubitemid 46850616)
13. Yeghiazarians Y, Braunstein JB, Askari A, Stone PH. Unstable angina pectoris. N Engl J Med 342: 101-114, 2000.
14. Zhang L, Liu Y, Lu XT, Wu YL, Zhang C, Ji XP, Wang R, Liu CX, Feng JB, Jiang H, Xu XS, Zhao YX, Zhang Y. Chinese herbal medication Tongxinluo dose-dependently enhances stability of vulnerable plaques: a comparison with a high-dose simvastatin therapy. Am J Physiol Heart Circ Physiol (September 18, 2009). doi:10.1152/ajpheart.00208. 2009.